Lanean...
Anti-IgE: A treatment option in allergic rhinitis?
Background: Allergic rhinitis (AR) is the most common IgE-mediated allergic disease. Multiple clinical trials have demonstrated promising results on the AR treatment with biologics, in particular with the use of omalizumab – an anti-IgE antibody. Omalizumab has also been established in the routine m...
Gorde:
| Argitaratua izan da: | Allergol Select |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dustri-Verlag Dr. Karl Feistle
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7905705/ https://ncbi.nlm.nih.gov/pubmed/33644635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/ALX02205E |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|